Ensweet

Founded in 2021 by Fabien Watrelot, Ensweet is a French MedTech company specializing in remote cardiac rehabilitation. Its hybrid solution, based on digital tools and expert human support, allows cardiac patients to access a home-based care program, in close collaboration with their medical team. Ensweet raised €3M in Seed funding in May 2025, in a round led by Mutuelles Impact, alongside AG2R LA MONDIALE, Angels Santé, Nord France Amorçage (NFA), 50 Partners, Finovam 2, and makesense, and several business angels specializing in health.